Primary hyperaldosteronism often results in resistant hypertension and hypokalemia, which may lead to cardiovascular and cerebrovascular complications. Although surgery is first line treatment for unilateral functioning aldosteronomas, minimally invasive therapies may be first line for certain patients such as those who cannot tolerate surgery. We present a case of transarterial embolization (T...

Psychiatric illnesses following cerebrovascular accidents has been a popular area of research in recent times. Though poststroke anxiety and mood disorders including depression have been reported often, reports of poststroke psychosis have been considerably rarer. This case report documents an even rarer occurrence of a psychotic disorder in an 8-year-old child with moyamoya disease following a...

Neurofibromatosis type 1 is a multisystem genetic disease of autosomal dominant transmission that reveals important cutaneous manifestations such as café-au-lait spots, multiple neurofibromas, and ephelides in skin fold areas, as well as hamartomatous lesions in the eyes, bones, glands, and central nervous system. Moyamoya disease is a rare progressive vaso-occlusive disorder that occurs with i...

The association of megaloblastic vitamin B12 deficiency anemia and essential thrombocythemia is very rarely described in the literature. We reported a case 65-year-old patient with an isolated chronic anemic syndrome secondary to treated therapy by injection. evolution was marked three months after treatment ischemic cerebrovascular accident thrombocytosis. Additional investigations confirmed thr...

Arterial hypertension is a major risk factor for cardiovascular disease.1 Epidemiological studies have provided unequivocal evidence for the association between arterial hypertension and mortality from ischemic heart disease, cerebrovascular accident (CVA), and vascular diseases.2 Additionally, there is a strong association between blood pressure (BP) reduction and prevention of coronary artery...

KEY CLINICAL MESSAGE Sorafenib is the standard treatment of hepatocellular carcinoma (HCC). However, fibrolamellar HCC was not included in sorafenib trials. The case is a 26-year-old man with fibrolamellar HCC, who had a cerebrovascular accident (CVA) while being treated with sorafenib. This illustrates a probable relationship between use of sorafenib and CVA in low cardiovascular risk patients.

A 26 year old woman with systemic lupus erythematosus, including malar rash, photosensitivity, and arthritis, developed a cerebrovascular accident and acute myocardial infarction. High titres to antinuclear factor, anti-DNA antibodies, positive Venereal Disease Research Laboratory (VDRL) test, and anticardiolipin antibodies were found in her serum. A possible association between the presence of...